Halozyme Announces Janssen Receives Two Positive CHMP Opinions for DARZALEX® (daratumumab) Subcutaneous Formulation Utilizing ENHANZE® prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Halozyme Reports First Quarter 2021 Results
- First Quarter Revenue of $89.0 million, Up from $25.4 million in First Quarter of 2020 -
- Record Quarterly Royalties in the First Quarter of $36.9 million Representing 119% Growth over First Quarter 2020 -
- Reiterate 2021 Revenue Guidance of $375 Million to $395 Million Representing 40% to 48% Growth over 2020 Revenue -
- Reiterate 2021 GAAP Operating Income Guidance of $215 million to $235 million, Representing 49%-63% Growth over 2020 GAAP Operating Income -
News provided by
Share this article
Share this article
SAN DIEGO, May 10, 2021 /PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the first quarter ended March 31, 2021 and provided an update on its recent corporate activities and outlook.
Halozyme to Present at BofA Securities 2021 Virtual Health Care Conference
News provided by
Share this article
Share this article
SAN DIEGO, April 29, 2021 /PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present virtually at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 12:30 p.m. Eastern Time / 9:30 a.m. Pacific Time
An audio-only direct link of the presentation can be accessed through the Investors section of www.halozyme.com, and a recording will be made available for 6 months following the event. To access the link, please visit Halozyme s website approximately 10 minutes prior to the presentation to register and download any necessary audio software.
Halozyme To Host First Quarter 2021 Financial Results Webcast And Conference Call
News provided by
Share this article
Share this article
SAN DIEGO, April 20, 2021 /PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2021 on Monday, May 10 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date, Halozyme will release financial results for the first quarter ended March 31, 2021 following the close of trading.
To register for this conference call, please use this link: http://www.directeventreg.com/registration/event/1584694. After registering, you will receive an email confirmation that includes dial in details and unique conference call codes for entry. Registration is open through the live call. However, to ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of